Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, United States; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, United States
Tanja Florin
Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, United States
Xinhao Shao
Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, United States
Dorota Klepacki
Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, United States
Irina Chelysheva
Institute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany
Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, United States; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, United States
Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, United States; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, United States
Biochemical studies suggested that the antimicrobial peptide apidaecin (Api) inhibits protein synthesis by binding in the nascent peptide exit tunnel and trapping the release factor associated with a terminating ribosome. The mode of Api action in bacterial cells had remained unknown. Here genome-wide analysis reveals that in bacteria, Api arrests translating ribosomes at stop codons and causes pronounced queuing of the trailing ribosomes. By sequestering the available release factors, Api promotes pervasive stop codon bypass, leading to the expression of proteins with C-terminal extensions. Api-mediated translation arrest leads to the futile activation of the ribosome rescue systems. Understanding the unique mechanism of Api action in living cells may facilitate the development of new medicines and research tools for genome exploration.